Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

A 9-Year retrospective review of antibiotic cycling in a surgical intensive care unit.

Sarraf-Yazdi S, Sharpe M, Bennett KM, Dotson TL, Anderson DJ, Vaslef SN.

J Surg Res. 2012 Aug;176(2):e73-8. doi: 10.1016/j.jss.2011.12.014.

2.

Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit.

Bennett KM, Scarborough JE, Sharpe M, Dodds-Ashley E, Kaye KS, Hayward TZ 3rd, Vaslef SN.

J Trauma. 2007 Aug;63(2):307-11.

PMID:
17693828
3.

In vivo comparison of CXA-101 (FR264205) with and without tazobactam versus piperacillin-tazobactam using human simulated exposures against phenotypically diverse gram-negative organisms.

Bulik CC, Tessier PR, Keel RA, Sutherland CA, Nicolau DP.

Antimicrob Agents Chemother. 2012 Jan;56(1):544-9. doi: 10.1128/AAC.01752-10.

4.
5.
6.
7.

Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital.

Petrikkos G, Markogiannakis A, Papaparaskevas J, Daikos GL, Stefanakos G, Zissis NP, Avlamis A.

Int J Antimicrob Agents. 2007 Jan;29(1):34-8. Erratum in: Int J Antimicrob Agents. 2007 Sep;30(3):287. Papapareskevas Joseph [corrected to Papaparaskevas, Joseph].

PMID:
17189092
8.

[Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].

Chen MJ, Wang H; China Nosocomial Pathogens Resistance Surveillance Study Group..

Zhonghua Yi Xue Za Zhi. 2003 Mar 10;83(5):375-81. Chinese.

PMID:
12820912
9.

Prevalence of antimicrobial resistance among gram-negative isolates in an adult intensive care unit at a tertiary care center in Saudi Arabia.

Al Johani SM, Akhter J, Balkhy H, El-Saed A, Younan M, Memish Z.

Ann Saudi Med. 2010 Sep-Oct;30(5):364-9. doi: 10.4103/0256-4947.67073.

10.

Association of antibiotic utilization measures and reduced incidence of infections with extended-spectrum beta-lactamase-producing organisms.

Lan CK, Hsueh PR, Wong WW, Fung CP, Lau YT, Yeung JY, Young GT, Su CC.

J Microbiol Immunol Infect. 2003 Sep;36(3):182-6.

PMID:
14582562
11.
13.
14.
15.

Piperacillin/tazobactam in the treatment of Klebsiella pneumoniae infections in neonates.

Pillay T, Pillay DG, Adhikari M, Sturm AW.

Am J Perinatol. 1998 Jan;15(1):47-51.

PMID:
9475688
16.

Broad-spectrum β-lactam antibiotics for treating experimental peritonitis in mice due to Klebsiella pneumoniae producing the carbapenemase OXA-48.

Mimoz O, Grégoire N, Poirel L, Marliat M, Couet W, Nordmann P.

Antimicrob Agents Chemother. 2012 May;56(5):2759-60. doi: 10.1128/AAC.06069-11.

17.
18.

Comparison of antimicrobial cycling and mixing strategies in two medical intensive care units.

Martínez JA, Nicolás JM, Marco F, Horcajada JP, Garcia-Segarra G, Trilla A, Codina C, Torres A, Mensa J.

Crit Care Med. 2006 Feb;34(2):329-36.

PMID:
16424711
19.

Impact of ceftazidime restriction on gram-negative bacterial resistance in an intensive care unit.

Brahmi N, Blel Y, Kouraichi N, Lahdhiri S, Thabet H, Hedhili A, Amamou M.

J Infect Chemother. 2006 Aug;12(4):190-4.

PMID:
16944257
20.

An observational study on the epidemiology of respiratory tract bacterial pathogens and their susceptibility to four injectable beta-lactam antibiotics: piperacillin, piperacillin/tazobactam, ceftazidime and ceftriaxone.

Varotto F, Maria GD, Azzaro R, Bellissima P, Amato R, Fogliani V, Muscianisi G, Vitale S, Girbino G, Andò F, Laganà P, Delia S, Jacoviello C, Maierna G, Pezza A, Covelli I, Magrì M, Napoletano G, Rossi A, Marone P, Sanguinetti C, Pela R, Tedeschi D, Viola B, Cicciarella S, Messina G, Rizza S, Fraschini F.

J Chemother. 2001 Aug;13(4):413-23. Erratum in: J Chemother 2001 Dec;13(6):666. Sabato V [corrected to Vitale S].

PMID:
11589485
Items per page

Supplemental Content

Support Center